Literature DB >> 11434671

Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male.

F Forloni1, M Giovilli, C Pecis, E Bortolani, A Preziosi, M E Barzaghi, D Corti, P Beck-Peccoz.   

Abstract

We describe an unusual case of bilateral breast cancer synchronous with pituitary macroprolactinoma in a young male. Up to date, only very few of such cases have been described worldwide and to our knowledge this is the first one in which both breast cancer and pituitary macroadenoma have been found together at the time of presentation. A 45-year-old male was diagnosed as having a pituitary macroprolactinoma and bilateral breast cancer on the basis of hypogonadism (testosterone 2.9 pmol/l) with very high levels of prolactin (33,100 U/l), typical neuroradiologic finding of a pituitary macroadenoma, marked bilateral gynecomastia with mammographic pattern highly suspected for cancer and subsequent hystological confirmation. Bilateral mastectomy was performed and medical therapy with bromocriptine 10 mg/day was started. After 2-year follow-up the patient is disease-free. Hormonal, neuroradiological and oncological patterns are all negative or markedly improved. We stress the importance of prolactin for its possible biological effects on breast cancer induction or growth. Moreover in any case of hyperprolactinemia we suggest a mammographic examination and, in the case of breast cancer, at least a baseline hormonal profile.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434671     DOI: 10.1007/BF03351047

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Insulin-like growth factor I disparately regulates prolactin and growth hormone synthesis and secretion: studies using the teleost pituitary model.

Authors:  S Fruchtman; L Jackson; R Borski
Journal:  Endocrinology       Date:  2000-08       Impact factor: 4.736

2.  Fracture of the sella turcica.

Authors:  F J Ortega; N S Longridge
Journal:  Injury       Date:  1975-05       Impact factor: 2.586

3.  Pituitary adenoma and bilateral male breast cancer: an unusual association.

Authors:  M D Volm; M S Talamonti; M Thangavelu; W K Gradishar
Journal:  J Surg Oncol       Date:  1997-01       Impact factor: 3.454

4.  Cellular expression of growth hormone and prolactin receptors in human breast disorders.

Authors:  H C Mertani; T Garcia-Caballero; A Lambert; F Gérard; C Palayer; J M Boutin; B K Vonderhaar; M J Waters; P E Lobie; G Morel
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

5.  Hypothalamic lesions following closed head injury.

Authors:  M R Crompton
Journal:  Brain       Date:  1971       Impact factor: 13.501

6.  [Bilateral carcinoma of the male breast. Analysis of a clinical case].

Authors:  M Giaume; G G Calcina; R Briglia
Journal:  Minerva Med       Date:  1986-05-31       Impact factor: 4.806

7.  Secretion of insulin-like growth factor-I (IGF-I) and IGF-binding proteins from bovine mammary tissue in vitro.

Authors:  P G Campbell; T C Skaar; J R Vega; C R Baumrucker
Journal:  J Endocrinol       Date:  1991-02       Impact factor: 4.286

Review 8.  Prolactin involvement in breast cancer.

Authors:  B K Vonderhaar
Journal:  Endocr Relat Cancer       Date:  1999-09       Impact factor: 5.678

9.  Prolactin and murine mammary tumorigenesis: a review.

Authors:  C W Welsch; H Nagasawa
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

10.  Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin.

Authors:  S Barni; P Lissoni; F Brivio; L Fumagalli; D Merlini; M Cataldo; F Rovelli; G Tancini
Journal:  Tumori       Date:  1994-06-30
View more
  8 in total

Review 1.  A rare case of male breast ductal carcinoma in-situ associated with prolactinoma.

Authors:  Chandike Maithri Mallawaarachchi; Snezana Ivanova; Alice Shorthouse; Sami Shousha; Dudley Sinnett
Journal:  BMJ Case Rep       Date:  2011-08-31

Review 2.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

3.  Arc and resistance welding and tumours of the endocrine glands: a Swedish case-control study with focus on extremely low frequency magnetic fields.

Authors:  N Håkansson; C Stenlund; P Gustavsson; C Johansen; B Floderus
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

Review 4.  Second cancers in patients with male breast cancer: a literature review.

Authors:  Tal Grenader; Anthony Goldberg; Linda Shavit
Journal:  J Cancer Surviv       Date:  2008-04-01       Impact factor: 4.442

Review 5.  Male breast carcinoma: increased awareness needed.

Authors:  Jonathan White; Olive Kearins; David Dodwell; Kieran Horgan; Andrew M Hanby; Valerie Speirs
Journal:  Breast Cancer Res       Date:  2011-09-29       Impact factor: 6.466

6.  Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.

Authors:  Rita Bettencourt-Silva; Joana Queirós; Josué Pereira; Davide Carvalho
Journal:  J Med Case Rep       Date:  2018-12-06

7.  The risk for breast cancer is not evidently increased in women with hyperprolactinemia.

Authors:  O M Dekkers; J A Romijn; A de Boer; J P Vandenbroucke
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

8.  Bilateral male breast cancer with male potential hypogonadism.

Authors:  Yukiko Hirose; Mitsunori Sasa; Yoshimi Bando; Toshiyuki Hirose; Tadaoki Morimoto; Yasushi Kurokawa; Taeko Nagao; Akira Tangoku
Journal:  World J Surg Oncol       Date:  2007-06-02       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.